Effect of bifenthrin on memory processes, movement activity, and coordination in mice exposed to transient cerebral oligaemia

• Autorzy: Nieradko-Iwanicka B , Borzecki A.
• Języki publikacji: EN

Abstrakty

EN

The purpose of the present study was to examine whether the effects of exposure to 0.1LD₅₀ of bifenthrin on memory processes, movement activity, and coordination could be exacerbated by transient reduction of cerebral oxygen supply. The transient occlusion of both common carotid arteries (BCCA) in adult mice was performed under anaesthesia. Intraperitoneal LD₅₀ for bifethrin was estimated to be 16.1mg/kg b.w. The memory retention was evaluated in a step-through passive avoidance task (PA), working spatial memory in a Y-maze, movement coordination on a rota-rod, and movement activity in an automated device. Long-term memory impairment caused by bifenthrin was exacerbated by BCCA. Movement co-ordination was significantly altered in animals treated with the compound. Movement activity was slightly decreased in animals after BCCA and pesticide injection. These results indicate that cerebral oligaemic hypoxia potentiates long-term memory impairing effect of bifenthrin.

Słowa kluczowe

EN

transient cerebral oligaemia; memory process; veterinary medicine; mouse; movement activity; bifenthrin; mice; neurotoxicity; animal disease

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2008
• Tom: 52
• Numer: 2
• Opis fizyczny: p.291-294,fig.,ref.

Twórcy

autor

Nieradko-Iwanicka B

• Medical University of Lublin, 20-080 Lublin, Poland

autor

Borzecki A.

Bibliografia

• 1. Allen D.G., Dyson D.H., Pascoe P.J., O'Grady M.R.: Evaluation of a xylazine-ketamine hydrochloride combination in the cat. Can J Vet Res 1986, 50, 23-26.
• 2. Baniadam A., Afshir F.S., Balani M.R.B.: Cardiopulmonary effects of acepromazine-ketamine administration in the sheep. Bull Vet Inst Pulawy 2007, 51, 93-96.
• 3. Dorman D.C., Beasley R.: Neurotoxicology of pyrethrin and the pyrethroid insecticides. Vet Hum Toxicol 1991, 33, 238-243.
• 4. Freeman C.: Acute oral toxicity study in rats: FMC 54800. FMC Corporation Study No. A83-859, 1982.
• 5. Freeman C.: FMC 54800 technical: subchronic neurotoxicity screen in rats. FMC Corporation Study No. A97-4700, 1998.
• 6. Heim C., Kolasiewicz W., Sontag K.-H.: The effects of the 21-aminosteroid U-74389G on spatial orientation in rats after a cerebral oligemic episode and iron-induced oxidative stress. Eur J Neurosci 2000, 12, 95-104.
• 7. Heim C., Sieklucka M., Block F., Schmidt-Kastner R., Jaspers R., Sontag K-H.: Transient occlusion of carotid arteries leads to disturbed learning and memory in the rat. In: Phamiacology of Cerebral Ischemia, Krieglstein J., Oberpilcher H. (Eds).Wiss.Verl.-Ges., Stuttgart, 1990, pp. 53-61.
• 8. Heim C., Zhang J., Lan J., Sieklucka M., Kurz T., Riederer P., Gerlach M., Sontag K-H: Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies. Eur J Neurosci 2000, 12, 715-725.
• 9. Jóźwiak L., Łukawski K., Czuczwar S.J., Sieklucka- Dziuba M.: Competitive NMDA receptor antagonists: effect on spontaneous alternation in mice exposed to cerebral oligemia. Pol J Pharmacol 2004, 56, 59-66.
• 10. Jóźwiak L. Sieklucka-Dziuba M., Kleinrok Z.: Behavioral studies of the effects of moderate oligemic hypoxia caused by bilateral clamping of carotid arteries in mice. Impairment of spatial working memory. Pol J Pharmacol 1998, 50, 529-535.
• 11. Lichtfield J.T., Wilcoxon F. A.: Simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
• 12. Muir W., Skarda R.T., Milne D.W.: Evaluation of xylazine and ketamine hydrochloride anesthesia in horses. Am J Vet Res 1977, 38, 195-201.
• 13. Rejdak K., Rejdak R., Stelmasiak Z., Czuczwar S.J., Kleinrok Z., Sieklucka-Dziuba M.: The effect of CGP- 40116 on pilocarpine evoked seizures in mice exposed to transient episode of brain ischemia. Epilepsy Res 2000, 41, 213-222.
• 14. Salfizadeh S., Pourjafar M., Naghadeh B., Jalali F.S.S.: Caudal extradural analgesia with lidocaine, xylazine, and a combination of lidocaine and xylazine in the Iranian river buffalo. Bull Vet Inst Pulawy 2007, 51, 285-288.
• 15. Schettgen T., Heudorf U., Drexler H., Angerer J.: Pyrethroid exposure of the general population - is this due to diet? Toxicol Letters 2002, 134, 141-145.
• 16. Soderlund D.M., Clark J.M., Sheets L.P., Mullin L.S., Piccirillo V.J., Sargent D., Stevens J.T., Weiner M.L.: Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology 2002, 171, 3-59.
• 17. Song J.H., Narahashi T.: Modulation of sodium channels of rat cerebellar Purkinje neurons by the pyrethroid tetramethrin. J Pharmacol Exp Ther 1996, 277, 445-453.
• 18. Stephenson J.C., Blevins D.I., Christie G.J.: Safety of Rompun / Ketaset combination in dogs. Vet Med Small Anim Clin 1978, 73, 303-305.
• 19. U.S. Environmental Protection Agency, Office Pesticides and Toxic Substances, Health Effects Test Guideline 870.6200, Neurotoxicity Screening Battery 1998.
• 20. Watt B.: FMC 54800 technical: acute neurotoxicity screen in rats. FMC Corporation Study No. A97-4643, 1998.